Prostate cancer originates in the male prostate gland and has become one of the most common types of cancer. It typically remains confined in this region, however it may spread to other locations throughout the body. Risk of prostate cancer increases with age, family history, obesity, and ethnicity as black males are the most likely to develop prostate cancer. Treatment for prostate cancer includes radiation therapy, hormone therapy, surgery, and chemotherapy. Stage II of prostate cancer can be divided into stage IIA or IIB. In stage II, the cancer has not spread outside of the prostate. In stage IIA, PSA levels are typically between 10 and 20 and Gleason scores are below 7. It is found to be around 1/2 of one lobe of the prostate. In stage IIB, PSA levels can be any level and Gleason scores range from 2-10. It may be found on opposite sides of the prostate or during a rectal exam. At this point, the tumor is not visible through imaging.
Stage B Prostate Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage B Prostate Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 864 products for the study of Stage B Prostate Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.